Pay in 4 interest-free payments of $5.08 Learn more
Ships within 48 hours · Estimated delivery Sep 6 - Sep 11
46c, 875881
Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation
Acknowledgements This work was supported by Noncommunicable Chronic Diseases-National Science and Technology Major Program (award no
Tail vein (165, 166), hepatic vein (167) and peripheral vein (168) injection of MSCs in an ischaemia-reperfusion injury animal model showed that MSC infusion can reduce liver damage and cell death (165, 167), improve the levels of ALT and AST (166168) and mainly decrease oxidative stress caused by liver excision and ischaemia-reperfusion injury (169)
Shock, 40 (4), 281
US$ 23.41
US$ 20.61
US$ 24.78
US$ 21.44
US$ 28.51
US$ 27.34
US$ 20.05
